Study to Evaluate Two Lenalidomide Dose Regimens With Low Dose Dexamethasone for the Treatment Relapsed Multiple Myeloma
This study is currently recruiting participants.
Verified February 2013 by Boston VA Research Institute, Inc.
Sponsor:
Boston VA Research Institute, Inc.
Collaborators:
Celgene Corporation
Kansas City Veteran Affairs Medical Center
VA Pittsburgh Healthcare System
VA Greater Los Angeles Healthcare System
Michael Debakey Veterans Affairs Medical Center
Edward Hines Jr. VA Hospital
Information provided by (Responsible Party):
Nikhil Munshi, M.D., Boston VA Research Institute, Inc.
ClinicalTrials.gov Identifier:
NCT01380106
First received: June 22, 2011
Last updated: February 4, 2013
Last verified: February 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | December 2016 |
| Estimated Primary Completion Date: | September 2016 (Final data collection date for primary outcome measure) |